Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raffaele Marfella

Showing results (271-280 of 306) with videos related to

Pageof 31
Sort By:
International Journal of Molecular Sciences|April 28, 2023
HBV Infection and Host Interactions: The Role in Viral Persistence and OncogenesisRiccardo Nevola, Domenico Beccia, Valerio Rosato, et al.
Biology|July 29, 2023
Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular CarcinomaRiccardo Nevola, Giovanni Tortorella, Valerio Rosato, et al.
Cancers|June 10, 2023
Neoadjuvant and Adjuvant Systemic Therapies in Loco-Regional Treatments for Hepatocellular Carcinoma: Are We at the Dawn of a New Era?Riccardo Nevola, Augusto Delle Femine, Valerio Rosato, et al.
BMC Medicine|February 24, 2023
SGLT-2 inhibitors and in-stent restenosis-related events after acute myocardial infarction: an observational study in patients with type 2 diabetesRaffaele Marfella, Celestino Sardu, Nunzia D'Onofrio, et al.
Circulation. Cardiovascular Quality and Outcomes|November 16, 2021
Survival in Patients With Suspected Myocardial Infarction With Nonobstructive Coronary Arteries: A Comprehensive Systematic Review and Meta-Analysis From the MINOCA Global CollaborationSivabaskari Pasupathy, Bertil Lindahl, Peter Litwin, et al.
Cardiovascular Diabetology|August 5, 2022
Glycated ACE2 reduces anti-remodeling effects of renin-angiotensin system inhibition in human diabetic heartsRaffaele Marfella, Nunzia D'Onofrio, Gelsomina Mansueto, et al.
Molecular Metabolism|September 9, 2021
Sodium-glucose co-transporter2 expression and inflammatory activity in diabetic atherosclerotic plaques: Effects of sodium-glucose co-transporter2 inhibitor treatmentNunzia D'Onofrio, Celestino Sardu, Maria Consiglia Trotta, et al.
Pharmacological Research|January 15, 2023
Reply to SGLT-2 inhibitors: Post-infarction interventional effectsPasquale Paolisso, Luca Bergamaschi, Felice Gragnano, et al.
European Journal of Preventive Cardiology|February 11, 2026
Phenotypes of Vulnerability and Prognosis in Older Adults with Cardiovascular DiseaseCarlo Fumagalli, Giulia Vetere, Greta Pini, et al.
Pharmacological Research|December 5, 2022
Outcomes in diabetic patients treated with SGLT2-Inhibitors with acute myocardial infarction undergoing PCI: The SGLT2-I AMI PROTECT RegistryPasquale Paolisso, Luca Bergamaschi, Felice Gragnano, et al.
Pageof 31

Showing results (271-280 of 306) with videos related to

Sort By:
Pageof 31
International Journal of Molecular Sciences|April 28, 2023
HBV Infection and Host Interactions: The Role in Viral Persistence and OncogenesisRiccardo Nevola, Domenico Beccia, Valerio Rosato, et al.
Biology|July 29, 2023
Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular CarcinomaRiccardo Nevola, Giovanni Tortorella, Valerio Rosato, et al.
Cancers|June 10, 2023
Neoadjuvant and Adjuvant Systemic Therapies in Loco-Regional Treatments for Hepatocellular Carcinoma: Are We at the Dawn of a New Era?Riccardo Nevola, Augusto Delle Femine, Valerio Rosato, et al.
BMC Medicine|February 24, 2023
SGLT-2 inhibitors and in-stent restenosis-related events after acute myocardial infarction: an observational study in patients with type 2 diabetesRaffaele Marfella, Celestino Sardu, Nunzia D'Onofrio, et al.
Circulation. Cardiovascular Quality and Outcomes|November 16, 2021
Survival in Patients With Suspected Myocardial Infarction With Nonobstructive Coronary Arteries: A Comprehensive Systematic Review and Meta-Analysis From the MINOCA Global CollaborationSivabaskari Pasupathy, Bertil Lindahl, Peter Litwin, et al.
Cardiovascular Diabetology|August 5, 2022
Glycated ACE2 reduces anti-remodeling effects of renin-angiotensin system inhibition in human diabetic heartsRaffaele Marfella, Nunzia D'Onofrio, Gelsomina Mansueto, et al.
Molecular Metabolism|September 9, 2021
Sodium-glucose co-transporter2 expression and inflammatory activity in diabetic atherosclerotic plaques: Effects of sodium-glucose co-transporter2 inhibitor treatmentNunzia D'Onofrio, Celestino Sardu, Maria Consiglia Trotta, et al.
Pharmacological Research|January 15, 2023
Reply to SGLT-2 inhibitors: Post-infarction interventional effectsPasquale Paolisso, Luca Bergamaschi, Felice Gragnano, et al.
European Journal of Preventive Cardiology|February 11, 2026
Phenotypes of Vulnerability and Prognosis in Older Adults with Cardiovascular DiseaseCarlo Fumagalli, Giulia Vetere, Greta Pini, et al.
Pharmacological Research|December 5, 2022
Outcomes in diabetic patients treated with SGLT2-Inhibitors with acute myocardial infarction undergoing PCI: The SGLT2-I AMI PROTECT RegistryPasquale Paolisso, Luca Bergamaschi, Felice Gragnano, et al.
Pageof 31